Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom

BACKGROUND: Dosing of renin–angiotensin–aldosterone system inhibitors (RAASi) may be modified to manage associated hyperkalemia risk; however, this approach could adversely affect cardiorenal outcomes. This study investigated real‐world associations of RAASi dose, hyperkalemia, and adverse clinical...

詳細記述

保存先:
書誌詳細
出版年:J Am Heart Assoc
主要な著者: Linde, Cecilia, Bakhai, Ameet, Furuland, Hans, Evans, Marc, McEwan, Phil, Ayoubkhani, Daniel, Qin, Lei
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2019
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6915283/
https://ncbi.nlm.nih.gov/pubmed/31711387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.012655
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料